Today: 8 februari 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3e-pl- Page 175

Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture (SCNX) shares surged 40% to $0.99 pre-market Nov. 4 after its hypertension drug Arbli™ was added to major insurance formularies, expanding coverage to over 100 million people. The company reported just $0.13 million in revenue and a $20 million net loss over the past year. SCNX trades near $0.71, down from a 52-week high of $8.81. Analysts remain cautious, citing high cash burn and uncertain Arbli sales.
4 november 2025
·
Upwork Stock Soars on AI-Fueled Earnings Beat – Key Facts & Expert Outlook

Upwork Stock Soars on AI-Fueled Earnings Beat – Key Facts & Expert Outlook

Upwork reported Q3 2025 revenue of $201.7 million, beating estimates, and raised its full-year outlook above consensus. Shares surged nearly 20% to around $17 after the results. Wall Street analysts boosted price targets, with Goldman Sachs setting a $25 target citing AI-driven growth. AI-related freelance work on the platform jumped 53% year-over-year.
4 november 2025
···
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Soars to Record High After Huge Q4 Earnings Beat – What’s Next for AAPL in 2025?

Apple traded near $269 on Nov. 4, 2025, close to its 52-week high of $277.32, with shares up 26% since August and market cap at $3.95 trillion. The company reported record Q4 revenue of $102.5 billion, up 8% year-over-year, and forecast double-digit iPhone sales growth for the holiday quarter. Analyst targets are split, with consensus near $285. Technical resistance is seen at $275–$280.
4 november 2025
···
Oriental Rise’s Wild Tea Ride: From $56 High to Penny Stock – 2025’s Shocking Ups and Downs Revealed

Oriental Rise’s Wild Tea Ride: From $56 High to Penny Stock – 2025’s Shocking Ups and Downs Revealed

Oriental Rise Holdings (NASDAQ: ORIS) closed at $0.19 on Nov 4, 2025, down 95% from its IPO, after a year of extreme volatility and a July share offering that triggered a 66% one-day crash. The China-based tea company reported 2024 revenue of $15 million (–38% YoY) and net income of $2.09 million (–82%), despite holding $43 million in cash and no debt. ORIS risks Nasdaq delisting unless it regains compliance by Dec 29.
4 november 2025
·
Arista Networks Stock Skyrockets 40% YTD on AI Boom – But Q3 Guidance Triggers Pullback

Arista Networks Stock Skyrockets 40% YTD on AI Boom – But Q3 Guidance Triggers Pullback

Arista Networks shares surged nearly 40% year-to-date in 2025, far outpacing the S&P 500. The stock hit a record high in late October before dropping about 12% after Q3 earnings, as guidance signaled flat Q4 revenue and lower margins. Q3 revenue rose 27.5% to $2.31 billion, beating estimates. Most analysts remain positive, but some cite high valuation and slowing growth.
5 november 2025
·
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Technologies’ shares have surged over 150% in 2025, hitting an all-time high near $207 before a post-earnings dip to the upper-$180s. Q3 revenue soared 63% to $1.18 billion, with U.S. commercial sales more than doubling. The company posted $0.18 GAAP EPS and $540 million in free cash flow. Michael Burry disclosed a large bearish bet, while Jim Cramer raised his price target to $200.
5 november 2025
···
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense shares fell to the mid-$70s after Q3 revenue beat estimates but Q4 guidance missed forecasts, cutting market cap to $13 billion. The company announced a $356.3 million cash acquisition of Israel’s Orbit Technologies and raised 2025 revenue guidance. Year-to-date, the stock is up over 300%, hitting a 21-year high in October. Analyst consensus is “Moderate Buy” with targets ranging from $77 to $125.
5 november 2025
···
Samsung Confirms 10.7Gbps LPDDR6 and 14.8GB/s Gen5 PM9E1 SSD Ahead of CES 2026

Samsung Confirms 10.7Gbps LPDDR6 and 14.8GB/s Gen5 PM9E1 SSD Ahead of CES 2026

Samsung will debut 10.7Gbps LPDDR6 DRAM and a compact Gen5 PM9E1 SSD with up to 14.8GB/s read and 13.4GB/s write speeds at CES 2026 in Las Vegas. The 12nm LPDDR6 offers about 21% better energy efficiency over previous models. The PM9E1 SSD features a 42mm M.2 form factor, “Presto” controller, V8 TLC V-NAND, and up to 4TB capacity. Both products are CES Innovation Awards honorees.
8 november 2025
··
E. coli Alert: France Recalls Reblochon de Savoie AOP Sold at E.Leclerc, Grand Frais and Fresh — What to Check Now (November 10, 2025)

E. coli Alert: France Recalls Reblochon de Savoie AOP Sold at E.Leclerc, Grand Frais and Fresh — What to Check Now (November 10, 2025)

French authorities recalled two Reblochon de Savoie AOP cheeses for E. coli STEC O26 contamination: E.Leclerc’s “Nos Régions ont du Talent” (lots 5-258, 5-258V) and Masson Reblochon sold at Grand Frais and Fresh (lot 5-258V). Products were sold nationwide between October and November 2025. Consumers are told not to eat the cheese and to return or destroy it for a refund. Recall ends November 21 or 26, depending on retailer.
10 november 2025
Nextracker Rebrands as Nextpower: NXT Stock Slips as Company Unveils Power‑Conversion Push and Long‑Term Targets (Nov. 12, 2025)

Nextracker Rebrands as Nextpower: NXT Stock Slips as Company Unveils Power‑Conversion Push and Long‑Term Targets (Nov. 12, 2025)

Nextracker Inc. has changed its name to Nextpower Inc. and unveiled a new power-conversion systems line, set to ship in 2026. The company reaffirmed FY26 guidance, introduced FY27 outlook, and targets $4.8–$5.6 billion revenue by FY30, with about one-third from non-tracker products. Shares fell 9.4% to $95.88 after the announcement. The Nasdaq ticker remains NXT.
12 november 2025
··
Nuvve Holding (NVVE) Soars on Japan Storage Deal as Q3 2025 Earnings Loom

Nuvve Holding (NVVE) Soars on Japan Storage Deal as Q3 2025 Earnings Loom

Nuvve shares surged over 130% in after-hours trading Wednesday after its Japanese subsidiary announced an aggregation deal for a 1.999 MW battery project in Tainai City, Niigata Prefecture. Pre-market quotes Thursday showed gains near 190%, with more than 222 million shares traded. The company remains at risk of Nasdaq delisting despite the spike. Q3 earnings are due after the close.
13 november 2025
·
Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson’s $3.05 Billion Halda Therapeutics Deal Signals New Oncology Push After Stelara Patent Cliff

Johnson & Johnson will acquire Halda Therapeutics for $3.05 billion in cash, expanding its oncology portfolio. Halda’s lead drug candidate targets advanced prostate cancer. The deal is expected to close in the coming months, pending regulatory approval. J&J faces declining Stelara sales as biosimilar competition increases.
17 november 2025
··
Compass-Backed Lugano Diamonds Files for Chapter 11 Bankruptcy Amid Fraud Allegations and Luxury Retail Slowdown

Compass-Backed Lugano Diamonds Files for Chapter 11 Bankruptcy Amid Fraud Allegations and Luxury Retail Slowdown

Lugano Diamonds & Jewelry Inc. filed for Chapter 11 bankruptcy in Delaware and put itself up for sale after internal probes revealed financial irregularities and lawsuits linked to ex-CEO Moti Ferder. The company lists over $500 million in liabilities and at least $100 million in assets. Majority owner Compass Diversified acquired its 60% stake in 2021. Boutiques remain open during the court-supervised sale process.
18 november 2025
·
Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Target Stock Slips as Q3 2025 Sales Fall and New CEO Bets on AI, Price Cuts and $5 Billion Store Upgrade Plan

Target reported a 1.6% drop in Q3 revenue to $25.27 billion, with comparable sales down 2.7%. Adjusted EPS beat expectations at $1.78, but fell from last year. The company cut its profit outlook and announced a turnaround plan focused on price cuts, store upgrades, and new AI partnerships. Shares fell nearly 2% pre-market, extending a year of steep losses.
19 november 2025
··
Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific shares fell 2.6% to $96.60 in late trading Wednesday, extending a three-day slide despite new research highlighting neuromodulation growth and recent acquisitions. The stock remains in the upper half of its 52-week range, with a market cap near $145–150 billion and trading at about 53 times trailing earnings.
19 november 2025
1 … 173 174 175 176

Stock Market Today

Go toTop